Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Variable Phenotype in Three Siblings With RAN Binding Protein 2 Variant With Potential Preventive Treatment for Recurrences.
[THE EVALUATION OF EFFICIENCY OF REORGANIZATION OF MEDICAL CARE UNDER DISSEMINATED SCLEROSIS ON THE BASIS OF ANALYSIS OF DYNAMICS OF TREATMENT WITH MEDICATIONS ALTERING COURSE OF DISSEMINATED SCLEROSIS].
Association of long-term outdoor air pollution exposure with incidence of Parkinson's disease, multiple sclerosis and motor neuron diseases: a systematic review and meta-analysis.
Multiple sclerosis during an emergency or crisis: A narrative review focused on the effect of war and COVID-19 pandemic.
Microglia-mediated neuroinflammation and demyelination contribute to pain and social behavioral deficits after spared nerve injury.
Associations of chronic low back pain with disability and health-related quality of life outcomes in people with Multiple Sclerosis: a cross-sectional survey study.
Lactylation drives oligodendrocyte differentiation and (re)myelination.
Tumefactive demyelinating disorders as neoplasm mimics: description of a typical case and literature review.
Erdheim-Chester Disease Presenting as Optic Neuritis: A Case Report and Review of the Literature.
A ketamine/methionine exposure paradigm, alone or combined with Lactobacillus rhamnosus GG, assessing schizophrenia-relevant behavioral, oxidative stress, and molecular endpoints in adult zebrafish.
Mitochondrial microprotein MOCCI controls neuroinflammation by altering glial activation states.
Walking as a Window to the Brain: Redefining Gait in Neurology.
MicroRNA Expression Profiles as Biomarkers of Response to Disease-Modifying Therapies in Multiple Sclerosis: A Systematic Review.
Synergy of Extremely Low-Frequency Electromagnetic Fields (ELFEFs) and Sex Hormones Against Oxidative Stress in Multiple Sclerosis.
ACUTE MACULAR NEURORETINOPATHY-LIKE LESIONS AS AN OCT-DEFINED PHENOTYPE: A SPECTRUM FROM ISCHEMIA TO INFLAMMATION.
Suicide in neurodegenerative diseases: a systematic review.
A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot-Marie-Tooth disease type 1.
Presynaptic release-regulating C5a receptors in the spinal cord of healthy mice and of animals suffering from experimental autoimmune encephalomyelitis: impact of the C5aR antagonist DF2593A.
Testing the construct validity of real-world digital mobility outcomes in multiple sclerosis.
Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes.
A shock-induced damage progression analysis on myelin sheath using molecular simulations.
Natural flavonoids in multiple sclerosis: molecular insights and emerging therapeutic strategies.
Transcriptomic profiling and structural characterization reveal UQCRC1 and COX4I1 as key mitochondrial regulators associated with oxidative stress in multiple sclerosis.
Recent Advances in Imaging of Demyelinating and Dysmyelinating White Matter Lesions.
Role of sirtuin 2 in the brain is cell-type and context-dependent: Implications for therapeutic targeting.

Pages